{
  "id": "0c340fc8-5f5e-45e0-8d8a-5269b2e3d5cb",
  "title": "Dr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boom",
  "link": "https://economictimes.indiatimes.com/markets/stocks/earnings/dr-lal-path-labs-q4-results-co-beats-quarterly-profit-view-on-medical-testing-boom/articleshow/120615946.cms",
  "description": "Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising health awareness in the country.",
  "author": "",
  "published": "Fri, 25 Apr 2025 15:36:20 +0530",
  "source": "https://economictimes.indiatimes.com/rssfeedsdefault.cms",
  "categories": null,
  "byline": "Reuters",
  "length": 2965,
  "excerpt": "Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising health awareness in the country.",
  "siteName": "Economic Times",
  "favicon": "",
  "text": "Dr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boomDr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boomReutersLast Updated: Apr 25, 2025, 03:38:00 PM ISTDr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising health awareness in the country.ETMarkets.comDr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising health awareness in the country. The company's consolidated net profit jumped 83.2% year-on-year to 1.55 billion rupees (about $18 million) in the quarter ended March 31, beating analysts' average estimate of 1.02 billion rupees, as per data compiled by LSEG. Dr Lal's shares, which were trading down 1.2%, jumped nearly 6% after results. A rising emphasis on preventive healthcare, along with the expansion of diagnostics firms like Dr Lal Path Labs into smaller cities, has fueled demand for medical tests, especially in urban India. Moreover, the company benefited from strong demand for its bundled tests offerings, which combine tests for multiple conditions, such as diabetes and thyroid, under one, analysts said.Live Events Dr Lal, which operates about 300 clinical labs across India, saw a 9.5% y/y rise in sample volume in the reported quarter, taking its total revenue from operations 10.5% higher to 6.03 billion rupees. Analysts expected revenue to come in at 6.04 billion rupees. Rival Metropolis Healthcare will report its March-quarter results in the coming weeks. ($1 = 85.4100 Indian rupees)Read More News on(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Online.and Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price...moreless(You can now subscribe to our ETMarkets WhatsApp channel)Read More News on(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Online.and Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price...morelessStories you might be interested in",
  "image": "https://img.etimg.com/thumb/msid-120615980,width-1200,height-630,imgsize-1291346,overlay-etmarkets/articleshow.jpg",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e  \u003cmain tabindex=\"-1\" role=\"presentation\" aria-hidden=\"true\"\u003e\u003cheader\u003e\u003c/header\u003e\u003cdiv data-key=\"\" data-et=\"2025-04-25 15:39:15.837\" data-ga-category=\"WEB Articleshow Clicks\" data-blacklist=\"0\" data-article_id=\"120615946\" data-hostid=\"153\" data-artitype=\"ET Free\" data-artdate=\"Apr 25, 2025, 03:36:00 PM IST\" data-arttitle=\"Dr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boom\" data-artseo=\"markets/stocks/earnings/dr-lal-path-labs-q4-results-co-beats-quarterly-profit-view-on-medical-testing-boom\" data-agency=\"Reuters\" data-authors=\"\" data-artidate=\"Apr 25, 2025, 03:36:00 PM IST\" data-hyp1=\"Quarter,Demand,Revenue,Dr Lal Path Labs,medical testing boom,India diagnostics market,metropolis healthcare\" data-keywords=\"Quarter,Demand,Revenue,Dr Lal Path Labs,medical testing boom,India diagnostics market,metropolis healthcare\" data-publish-type=\"Native - 120615946\" data-audcnt=\"No\" data-vidcnt=\"No\" data-age=\"\u0026lt;72hrs\" data-no-of-words=\"201.0\" data-subsec2=\"2146842\"\u003e\u003cdiv\u003e\u003ch3 data-ga-action=\"Filter\"\u003e\u003cspan\u003e\u003c/span\u003e\u003c/h3\u003e\u003ch2\u003eDr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boom\u003c/h2\u003e\u003c/div\u003e\u003cdiv\u003e\u003cdiv\u003eDr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boom\u003c/div\u003e\u003cspan\u003eReuters\u003c/span\u003e\u003cspan\u003e\u003c/span\u003e\u003ctime data-dt=\"1745575680000\"\u003eLast Updated: Apr 25, 2025, 03:38:00 PM IST\u003c/time\u003e\u003c/div\u003e\u003cdiv\u003e\u003cdiv\u003e\u003ch2\u003eDr Lal Path Labs, India\u0026#39;s largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising health awareness in the country.\u003c/h2\u003e\u003c/div\u003e\u003carticle competitionclients=\"\" currency_ad=\"1\" data-apw=\"1\" data-company-id=\"16325\"\u003e\u003cdiv\u003e\u003cfigure\u003e\u003cimg height=\"158\" width=\"210\" alt=\"Dr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boom\" src=\"https://img.etimg.com/thumb/msid-120615980,width-210,height-158,imgsize-1291346,resizemode-75/dr-lal-path-labs-q4-results-co-beats-quarterly-profit-view-on-medical-testing-boom.jpg\"/\u003e\u003cspan\u003eETMarkets.com\u003c/span\u003e\u003c/figure\u003e\u003c/div\u003e\u003cdiv data-brcount=\"13\"\u003e\u003ca ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#Markets#href\" href=\"https://economictimes.indiatimes.com/topic/dr-lal-path-labs\" target=\"_blank\"\u003eDr Lal Path Labs\u003c/a\u003e, India\u0026#39;s largest diagnostics firm by \u003ca ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#Markets#href\" href=\"https://economictimes.indiatimes.com/topic/revenue\" target=\"_blank\"\u003erevenue\u003c/a\u003e, reported fourth-quarter profit above expectations on Friday as strong \u003ca data-ga-onclick=\"Inarticle articleshow link click#Markets#href\" target=\"_blank\" href=\"https://economictimes.indiatimes.com/definition/demand\"\u003edemand\u003c/a\u003e for its bundled test packages lifted growth amid rising health awareness in the country.\u003cp\u003e The company\u0026#39;s consolidated net profit jumped 83.2% year-on-year to 1.55 billion rupees (about $18 million) in the \u003ca data-ga-onclick=\"Inarticle articleshow link click#Markets#href\" target=\"_blank\" href=\"https://economictimes.indiatimes.com/definition/quarter\"\u003equarter\u003c/a\u003e ended March 31, beating analysts\u0026#39; average estimate of 1.02 billion rupees, as per data compiled by LSEG.\u003c/p\u003e\u003cbr/\u003e Dr Lal\u0026#39;s shares, which were trading down 1.2%, jumped nearly 6% after results.\u003cp\u003e A rising emphasis on preventive healthcare, along with the expansion of diagnostics firms like Dr Lal Path Labs into smaller cities, has fueled demand for medical tests, especially in urban India.\u003c/p\u003e\u003cbr/\u003e Moreover, the company benefited from strong demand for its bundled tests offerings, which combine tests for multiple conditions, such as diabetes and thyroid, under one, analysts said.\u003cbr/\u003e\u003cdiv data-ga-impression=\"Events_widget_$pagename#Impression#url\"\u003e\u003cdiv\u003e\u003cimg alt=\"ET logo\" src=\"https://img.etimg.com/photo/118783427.cms\" width=\"90%\"/\u003e\u003c/div\u003e\u003ch3\u003eLive Events\u003c/h3\u003e\u003c/div\u003e\u003cbr/\u003e Dr Lal, which operates about 300 clinical labs across India, saw a 9.5% y/y rise in sample volume in the reported quarter, taking its total revenue from operations 10.5% higher to 6.03 billion rupees. Analysts expected revenue to come in at 6.04 billion rupees. Rival \u003ca rel=\"dofollow\" href=\"https://economictimes.indiatimes.com/metropolis-healthcare-ltd/stocks/companyid-16325.cms\" data-ga-onclick=\"Inarticle articleshow link click#Markets#href\" target=\"_blank\"\u003eMetropolis Healthcare\u003c/a\u003e will report its March-quarter results in the coming weeks. ($1 = 85.4100 Indian rupees)\u003cbr/\u003e\u003c/div\u003e\u003cdiv data-ga-action=\"Widget Read More News\"\u003e\u003ch4\u003eRead More News on\u003c/h4\u003e\u003c/div\u003e\u003cdiv\u003e\u003cdiv\u003e\u003cp\u003e(What\u0026#39;s moving \u003ca href=\"https://economictimes.indiatimes.com/indices/sensex_30_companies\"\u003eSensex\u003c/a\u003e and \u003ca href=\"https://economictimes.indiatimes.com/indices/nifty_50_companies\"\u003eNifty\u003c/a\u003e Track \u003ca href=\"https://economictimes.indiatimes.com/markets/stocks\"\u003elatest market news\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/markets/stocks/recos\"\u003estock tips\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/budget\"\u003eBudget 2025\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/markets/stocks/live-blog/bse-sensex-today-live-updates-nifty-50-stock-market-on-union-budget-2025-nirmala-sitharaman-speech-01-february-2025/liveblog/117809746.cms\"\u003eShare Market on Budget 2025\u003c/a\u003e and \u003ca href=\"https://economictimes.indiatimes.com/markets/expert-view\"\u003eexpert advice\u003c/a\u003e, on \u003ca href=\"https://economictimes.indiatimes.com/markets\"\u003eETMarkets\u003c/a\u003e. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, \u003ca rel=\"nofollow\" href=\"https://t.me/joinchat/J60pKE7SOStsj5sI8nDmHQ\" target=\"_blank\"\u003esubscribe to our Telegram feeds\u003c/a\u003e .)\u003c/p\u003e \u003cp\u003eSubscribe to \u003ca rel=\"nofollow\" href=\"https://buy.indiatimes.com/ET/plans\"\u003eET Prime\u003c/a\u003e and read the \u003ca rel=\"nofollow\" href=\"https://epaper.indiatimes.com/timesepaper/publication-the-economic-times,city-delhi.cms\"\u003eEconomic Times ePaper\u003c/a\u003e Online.and \u003ca href=\"https://economictimes.indiatimes.com/markets/stocks/live-blog/bse-sensex-today-live-nifty-stock-market-updates-5-june-2024/liveblog/110717623.cms\"\u003eSensex Today\u003c/a\u003e.\u003c/p\u003e \u003cp\u003eTop Trending Stocks: \u003ca href=\"https://economictimes.indiatimes.com/state-bank-of-india/stocks/companyid-11984.cms\"\u003eSBI Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/axis-bank-ltd/stocks/companyid-9175.cms\"\u003eAxis Bank Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/hdfc-bank-ltd/stocks/companyid-9195.cms\"\u003eHDFC Bank Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/infosys-ltd/stocks/companyid-10960.cms\"\u003eInfosys Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/wipro-ltd/stocks/companyid-12799.cms\"\u003eWipro Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/ntpc-ltd/stocks/companyid-12316.cms\"\u003eNTPC Share Price\u003c/a\u003e\u003c/p\u003e\u003c/div\u003e\u003cspan\u003e\u003cspan\u003e...\u003c/span\u003emore\u003c/span\u003e\u003cspan\u003eless\u003c/span\u003e\u003c/div\u003e\u003cdiv\u003e\u003cdiv\u003e\u003cbr/\u003e\u003cem\u003e(You can now subscribe to our \u003ca rel=\"nofollow\" href=\"https://www.whatsapp.com/channel/0029VaAr2nxHbFV91x3BKx10\" target=\"_blank\" data-ga-onclick=\"WhtsApChnl#Click_Web#Markets\"\u003eETMarkets WhatsApp channel\u003c/a\u003e)\u003cbr/\u003e\u003c/em\u003e\u003c/div\u003e\u003cdiv data-ga-action=\"Widget Read More News\"\u003e\u003ch4\u003eRead More News on\u003c/h4\u003e\u003c/div\u003e\u003cdiv\u003e\u003cp\u003e(What\u0026#39;s moving \u003ca href=\"https://economictimes.indiatimes.com/indices/sensex_30_companies\"\u003eSensex\u003c/a\u003e and \u003ca href=\"https://economictimes.indiatimes.com/indices/nifty_50_companies\"\u003eNifty\u003c/a\u003e Track \u003ca href=\"https://economictimes.indiatimes.com/markets/stocks\"\u003elatest market news\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/markets/stocks/recos\"\u003estock tips\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/budget\"\u003eBudget 2025\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/markets/stocks/live-blog/bse-sensex-today-live-updates-nifty-50-stock-market-on-union-budget-2025-nirmala-sitharaman-speech-01-february-2025/liveblog/117809746.cms\"\u003eShare Market on Budget 2025\u003c/a\u003e and \u003ca href=\"https://economictimes.indiatimes.com/markets/expert-view\"\u003eexpert advice\u003c/a\u003e, on \u003ca href=\"https://economictimes.indiatimes.com/markets\"\u003eETMarkets\u003c/a\u003e. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, \u003ca rel=\"nofollow\" href=\"https://t.me/joinchat/J60pKE7SOStsj5sI8nDmHQ\" target=\"_blank\"\u003esubscribe to our Telegram feeds\u003c/a\u003e .)\u003c/p\u003e \u003cp\u003eSubscribe to \u003ca rel=\"nofollow\" href=\"https://buy.indiatimes.com/ET/plans\"\u003eET Prime\u003c/a\u003e and read the \u003ca rel=\"nofollow\" href=\"https://epaper.indiatimes.com/timesepaper/publication-the-economic-times,city-delhi.cms\"\u003eEconomic Times ePaper\u003c/a\u003e Online.and \u003ca href=\"https://economictimes.indiatimes.com/markets/stocks/live-blog/bse-sensex-today-live-nifty-stock-market-updates-5-june-2024/liveblog/110717623.cms\"\u003eSensex Today\u003c/a\u003e.\u003c/p\u003e \u003cp\u003eTop Trending Stocks: \u003ca href=\"https://economictimes.indiatimes.com/state-bank-of-india/stocks/companyid-11984.cms\"\u003eSBI Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/axis-bank-ltd/stocks/companyid-9175.cms\"\u003eAxis Bank Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/hdfc-bank-ltd/stocks/companyid-9195.cms\"\u003eHDFC Bank Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/infosys-ltd/stocks/companyid-10960.cms\"\u003eInfosys Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/wipro-ltd/stocks/companyid-12799.cms\"\u003eWipro Share Price\u003c/a\u003e, \u003ca href=\"https://economictimes.indiatimes.com/ntpc-ltd/stocks/companyid-12316.cms\"\u003eNTPC Share Price\u003c/a\u003e\u003c/p\u003e\u003c/div\u003e\u003cspan\u003e\u003cspan\u003e...\u003c/span\u003emore\u003c/span\u003e\u003cspan\u003eless\u003c/span\u003e\u003c/div\u003e\u003c/article\u003e\u003c/div\u003e\u003c/div\u003e\u003c/main\u003e\u003cspan\u003e\u003c/span\u003e\u003cdiv\u003e\u003cspan\u003e\u003c/span\u003e\u003cp\u003eStories you might be interested in\u003c/p\u003e\u003cul\u003e\u003c/ul\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "4 min read",
  "publishedTime": "2025-04-25T15:36:00+05:30",
  "modifiedTime": null
}
